Is Now a Good Time to Buy Canopy Growth Corp (TSX:WEED)?

Canopy Growth Corp (TSX:WEED) (NYSE:CGC) is about a month away from releasing its financial results. Is now a good time to buy?

| More on:

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is the largest cannabis company in the world by market cap. Despite the firm being widely regarded as one of the best equipped to profit from the growing marijuana sector, many investors think Canopy is currently overvalued. However, Canopy’s share value has decreased by about 15% over the past month at writing. Is now a good time to purchase shares of the Ontario-based pot company?

Recent developments

Perhaps the biggest news Canopy made recently was its deal to acquire Acreage Holdings — a U.S.-based cannabis company — if marijuana becomes legal at the federal level in the U.S., this acquisition would obviously be significant for the firm. 

Despite Canada being the first industrialized country to legalize recreational uses of marijuana, the U.S. remains the largest market in the world. If pot is fully legalized south of the border and this acquisition goes through, Canopy would benefit in a major way. 

However, this news came with one important asterisk, namely, the fact that Canopy chose to finance a significant portion (over 90%) of this (potential) deal with its common stock.

Marijuana companies have been reverting to dilutive forms of financing since their early years. It was a necessary evil, as none of them had the funds necessary to finance their growth. But Canopy doing so at this stage isn’t great news for its shareholders, though the acquisition may end up being worth the hefty price tag. 

Canopy’s competitors release their earnings

In other news, most of Canopy’s peers have now released their Q1 2019 financial results, which should give us a clue as to what Canopy’s will look like. As a reminder, for the Q4 2018, Canopy was far and away the winner in terms of sales and revenues.

With revenues of $83 million (and about $10,100 kilograms of cannabis sold), Canopy outperformed Aurora Cannabis, Aphria and Tilray, which reported revenues of $54.2 million, $21.7 million, and $20.9 million, respectively.

During its latest quarter, Aurora posted gross revenues of $75.24 million and net revenues of $65.15 million. Though its gross revenues increased by about 367% year over year, it only represented a 38% quarter-to-quarter increase.

Investors can expect to see a similar progression in Canopy’s next earnings report, which should be released sometime next month. The company should also see an increase in its production capacity.

Is now a good time to buy?

Canopy still has some of the best prospects of any pot company. Despite its relatively high price tag, it may worth it to invest in the Ontario-based firm. Of course, some investors may feel that its share price is bound to decrease significantly at some point. It isn’t the worst idea to wait until that happens.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny owns shares of Aurora Cannabis.  

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »